Exhibit 4 AMENDMENT TO SECURITIES PURCHASE AGREEMENT THIS AMENDMENT TO SECURITIES PURCHASE AGREEMENT (this "Amendment") is entered into as this 28th day of September, 2000, by and among BioSource International, Inc., a Delaware corporation (the...Securities Purchase Agreement • October 26th, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
ARTICLE I.Securities Purchase Agreement • September 22nd, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances • California
SECOND AMENDMENT TO INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • October 26th, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
EXHIBIT 2 SECURITIES PURCHASE AGREEMENT ----------------------------- SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of January 10, 2000, by and among BIOSOURCE INTERNATIONAL, INC., a corporation organized under the laws of the State of...Securities Purchase Agreement • January 20th, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances • California
EXHIBIT 5 INVESTOR RIGHTS AGREEMENT INVESTOR RIGHTS AGREEMENT (this "Agreement"), dated as of February __, 2000, by and among BIOSOURCE INTERNATIONAL, INC., a corporation organized under the laws of the State of Delaware (the "Company"), and GENSTAR...Investor Rights Agreement • January 20th, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances • California
Exhibit 3 BIOSOURCE INTERNATIONAL 820 Flynn Road Camarillo, CA 93012Employment Agreement • September 7th, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
JOINT FILING AGREEMENT ----------------------Joint Filing Agreement • September 22nd, 2000 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) and Robert J. Weltman on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.001 per share, of BioSource International, Inc., a Delaware corporation, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK OF BIOSOURCE INTERNATIONAL, INC.Warrant to Purchase Common Stock • June 10th, 2004 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK (the “Amendment”), is entered into on this 7th day of June 2004, by and between BioSource International, Inc., a Delaware corporation (the “Company”), and Stargen II LLC (the “Holder”).
AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK OF BIOSOURCE INTERNATIONAL, INC.Warrant Amendment • June 10th, 2004 • Genstar Capital LLC • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 1 TO WARRANT TO PURCHASE COMMON STOCK (the “Amendment”), is entered into on this 7th day of June 2004, by and between BioSource International, Inc., a Delaware corporation (the “Company”), and Genstar Capital Partners II, L.P. (the “Holder”).
VOTING AGREEMENTVoting Agreement • July 29th, 2005 • Genstar Capital LLC • In vitro & in vivo diagnostic substances • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of July 25, 2005 by and among Invitrogen Corporation, a Delaware corporation (“Parent”), and the Stockholders listed on Annex A hereto (each, a “Stockholder” and, collectively, the “Stockholders”).
